Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Toronto

$34,000.00

Identification and characterization of interactome of glucagon receptor subfamily

EF 2015-16

Résumé
<span style=""text-decoration: underline;"">Research background: The Glucagon-subfamily receptors (GSRs) belong to the largest mammalian receptor family of G-protein coupled receptors (GPCRs). Most notably, the glucagon-like peptide 1 receptor (GLP1R), the Glucagon-like peptide-2 (GLP2R) receptor and the glucagon receptor (GcgR) are important for maintaining blood sugar levels in animals. The hormone GLP1, which binds to and activates the GLP1R, is responsible for glucose stimulated insulin secretion from pancreatic insulin producing cells to reduce blood sugar. In contrast, the major action of glucagon is to act through its receptor (GcgR) in the liver to increase glucose production to alleviate or prevent blood sugar from falling too low. GLP2 is found in mainly in intestinal cells and regulates among other things sugar absorption into the bloodstream. The activation of these GSRs like many other GPCRs, is mediated through accessory/interacting proteins, however for most receptors, these remain unknown and undiscovered. <span style=""text-decoration: underline;"">Overall goals and hypothesis: The overall goal of the present proposal is to discover and characterize novel proteins that directly interact with and modulate the activity of GLP1R, GLP2R and GcgR. Importantly, we provide substantial preliminary data showing that all three GSRs interact with novel unknown proteins that modify their function-providing very new information on how to control blood sugar. The overall hypothesis of this work is that the specific interactors of these GSRs identified here will significantly enhance or inhibit receptor activity and thus regulate blood sugar. <span style=""text-decoration: underline;"">Proposed experiments: We have developed two novel approaches, membrane yeast 2-hybrid (MYTH) system and mammalian cell affinity purification-mass spectrometry LC-MS/MS (AP-MS) to identify proteins that can interact with the mammalian GSRs. From these screens, collectively, we wish to identify and then functionally study the novel GSR proteins we find. We propose to carry out these studies in a specialized yeast system, in genetically modified cultured mammalian cells and in genetically engineered mice. We have already collected substantial preliminary data with both MYTH and AP-MS as mentioned above. Using AP/MS and GLP1R, we have discovered a novel membrane protein, PGRMC1, which links conventional GLP1R signaling in pancreatic cells to enhance the potency of GLP1 action. Using a similar strategy, we demonstrated that the protein YWHAB1 interacts with GcgR to inhibit glucagon action and thus affecting its ability to increase blood sugar in the liver. We now wish to substantially build upon these novel findings to provide new mechanistic insights into GPCR action. <span style=""text-decoration: underline;"">Significance: Overall we anticipate that our research will provide new mechanistic perspectives on how GPCR signaling is controlled to affect cell function, using the GSRs and the beta cell and hepatocyte as model systems.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2015-05286
Name nom
Wheeler, Michael
Department département
Physiology - Physiology
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5103
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell membranes
Research subject fr
Membranes cellulaires
Partie
1
Nb partie
1
Application title
Identification and characterization of interactome of glucagon receptor subfamily
Keyword
NSERC
Application summary
<strong><span style=""text-decoration: underline;""><em>Research background:</em></span></strong> The Glucagon-subfamily receptors (GSRs) belong to the largest mammalian receptor family of G-protein coupled receptors (GPCRs). Most notably, the glucagon-like peptide 1 receptor (GLP1R), the Glucagon-like peptide-2 (GLP2R) receptor and the glucagon receptor (GcgR) are important for maintaining blood sugar levels in animals. The hormone GLP1, which binds to and activates the GLP1R, is responsible for glucose stimulated insulin secretion from pancreatic insulin producing cells to reduce blood sugar. In contrast, the major action of glucagon is to act through its receptor (GcgR) in the liver to increase glucose production to alleviate or prevent blood sugar from falling too low. GLP2 is found in mainly in intestinal cells and regulates among other things sugar absorption into the bloodstream. The activation of these GSRs like many other GPCRs, is mediated through accessory/interacting proteins, however for most receptors, these remain unknown and undiscovered. <br /> <strong><span style=""text-decoration: underline;""><em>Overall goals and hypothesis:</em></span></strong> The overall goal of the present proposal is to discover and characterize novel proteins that directly interact with and modulate the activity of GLP1R, GLP2R and GcgR. Importantly, we provide substantial preliminary data showing that all three GSRs interact with novel unknown proteins that modify their function-providing very new information on how to control blood sugar. The overall hypothesis of this work is that the specific interactors of these GSRs identified here will significantly enhance or inhibit receptor activity and thus regulate blood sugar. <br /> <span style=""text-decoration: underline;""><strong><em>Proposed experiments:</em></strong></span> We have developed two novel approaches, membrane yeast 2-hybrid (MYTH) system and mammalian cell affinity purification-mass spectrometry LC-MS/MS (AP-MS) to identify proteins that can interact with the mammalian GSRs. From these screens, collectively, we wish to identify and then functionally study the novel GSR proteins we find. We propose to carry out these studies in a specialized yeast system, in genetically modified cultured mammalian cells and in genetically engineered mice. We have already collected substantial preliminary data with both MYTH and AP-MS as mentioned above. Using AP/MS and GLP1R, we have discovered a novel membrane protein, PGRMC1, which links conventional GLP1R signaling in pancreatic cells to enhance the potency of GLP1 action. Using a similar strategy, we demonstrated that the protein YWHAB1 interacts with GcgR to inhibit glucagon action and thus affecting its ability to increase blood sugar in the liver. We now wish to substantially build upon these novel findings to provide new mechanistic insights into GPCR action.<br /> <strong><span style=""text-decoration: underline;""><em>Significance:</em></span></strong> Overall we anticipate that our research will provide new mechanistic perspectives on how GPCR signaling is controlled to affect cell function, using the GSRs and the beta cell and hepatocyte as model systems.